Diabetes Mellitus: Type 2 and Gestational

In Type 2 diabetes, insulin receptors on cells stop responding to insulin, developing insulin resistance. This reduces the cell's ability to uptake glucose, causing blood glucose levels to rise. Unlike Type 1 diabetes where the pancreas fails to produce insulin, Type 2 involves a loss of cellular responsiveness to the hormone that is still being produced.

Blood glucose tests measure glucose levels to classify patients as normal, prediabetic, or diabetic based on cut-off values. Different tests provide varying measurements of blood sugar concentration. Results falling outside normal ranges indicate prediabetes or diabetes depending on severity, guiding clinical diagnosis and treatment decisions.

Type 2 diabetes is common in adults and associated with lack of physical activity, obesity, poor diet, and family history. These modifiable and non-modifiable risk factors increase susceptibility to insulin resistance. Lifestyle interventions targeting diet and exercise can help reduce risk in predisposed individuals.

Type 2 diabetic patients face risks of heart disease, amputations, kidney failure, and blindness. These complications result from prolonged hyperglycemia damaging blood vessels and nerves. Early diagnosis and comprehensive management through lifestyle modifications and medications are crucial for preventing these severe outcomes.

Type 2 diabetes management combines lifestyle changes including diet and exercise with pharmacological interventions. Oral antidiabetic drugs are typically prescribed first, with insulin therapy added if needed. This multifaceted approach helps restore glucose homeostasis and reduces complication risk in affected patients.

Gestational Diabetes Mellitus (GDM) occurs during pregnancy and can cause preterm labor, fetal overgrowth, and preeclampsia. Although GDM typically resolves after childbirth, both mothers and babies face lifelong risks of Type 2 diabetes, cardiovascular diseases, and obesity, requiring ongoing monitoring.

Mothers with GDM and their babies develop lifelong susceptibility to Type 2 diabetes, cardiovascular diseases, and obesity despite GDM resolution post-childbirth. This suggests shared metabolic predisposition and potential developmental factors. Early intervention and lifestyle management are essential for mitigating these persistent health risks.